One limitation of the present study is that we examined only two papillary thyroid carcinoma derived cell lines and were unable to assess the effects of NKX2-1 overexpression in other thyroid cancer cells, such as PDTC or anaplastic thyroid carcinoma. Here, NKX2-1 is linked to thyroid gland carcinoma.